B

Betta Pharmaceuticals Co Ltd
SZSE:300558

Watchlist Manager
Betta Pharmaceuticals Co Ltd
SZSE:300558
Watchlist
Price: 49.36 CNY -7.04% Market Closed
Market Cap: 20.7B CNY
Have any thoughts about
Betta Pharmaceuticals Co Ltd?
Write Note

Net Margin
Betta Pharmaceuticals Co Ltd

16.7%
Current
13%
Average
4.5%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
16.7%
=
Net Income
459.6m
/
Revenue
2.8B

Net Margin Across Competitors

Country CN
Market Cap 20.7B CNY
Net Margin
17%
Country JP
Market Cap 776 550.9T JPY
Net Margin
-79%
Country US
Market Cap 710.5B USD
Net Margin
20%
Country UK
Market Cap 440.4B GBP
Net Margin
-4%
Country DK
Market Cap 3.3T DKK
Net Margin
35%
Country US
Market Cap 373.5B USD
Net Margin
17%
Country US
Market Cap 251.1B USD
Net Margin
19%
Country CH
Market Cap 202.7B CHF
Net Margin
20%
Country CH
Market Cap 183.3B CHF
Net Margin
35%
Country UK
Market Cap 162.4B GBP
Net Margin
13%
Country IE
Market Cap 146B USD
Net Margin
-126%
No Stocks Found

Betta Pharmaceuticals Co Ltd
Glance View

Market Cap
20.7B CNY
Industry
Pharmaceuticals

Betta Pharmaceuticals Co., Ltd. engages in the research and development, production, and sale of anticancer targeted drugs. The company is headquartered in Hangzhou, Zhejiang and currently employs 1,677 full-time employees. The company went IPO on 2016-11-07. The firm's primary product is its self-developed icotinib hydrochloride (Conmana), a small molecule targeted anticancer drug used for the treatment of lung cancer. The firm is also engaged in promotional services, real estate leasing and other businesses.

Intrinsic Value
57.35 CNY
Undervaluation 14%
Intrinsic Value
Price
B

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
16.7%
=
Net Income
459.6m
/
Revenue
2.8B
What is the Net Margin of Betta Pharmaceuticals Co Ltd?

Based on Betta Pharmaceuticals Co Ltd's most recent financial statements, the company has Net Margin of 16.7%.